Management of Serially Elevated Lipase Without Abdominal Pain
Diagnostic Evaluation
- The American College of Gastroenterology recommends measuring both lipase and amylase levels, as lipase is more specific than amylase for pancreatic pathology 1
- Non-pancreatic causes of elevated lipase should be considered, including renal disease, appendicitis, acute cholecystitis, chronic pancreatitis, and bowel obstruction 2
- Medication-related causes, particularly tyrosine kinase inhibitors (TKIs) used in chronic myeloid leukemia, can also lead to elevated lipase levels 3, 4
- Immune checkpoint inhibitors used in cancer treatment can cause elevated lipase levels, according to the National Comprehensive Cancer Network 5
Monitoring Approach
- Serial lipase measurements every 6 hours are recommended to monitor for persistent elevation or rising trends 1
- Regular clinical examinations should be performed to assess for development of symptoms, including abdominal pain, nausea, vomiting, or anorexia 2, 5
Further Investigation
- Imaging studies, such as abdominal ultrasound or contrast-enhanced CT scan, should be considered if lipase levels are >3 times upper limit of normal, show a rising trend, or if the patient develops symptoms suggestive of pancreatitis 1, 2
- The American College of Radiology recommends abdominal ultrasound as the first-line imaging modality to detect gallstones, free peritoneal fluid, or biliary duct dilation 2
Management Based on Etiology
- For medication-related elevated lipase, dose adjustment or switching to a different medication may be necessary, according to the Leukemia society 3, 4
- For immune checkpoint inhibitor-related elevation, close monitoring for development of immune-related pancreatitis is recommended, according to the National Comprehensive Cancer Network 5